This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Icosagen Cell Factory Ou. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: The Innovations of Anne Kalling
Introduction
Anne Kalling is a notable inventor based in Tartu, Estonia. She has made significant contributions to the field of biotechnology, particularly in the development of viral expression plasmids. Her work has implications for the production of proteins, antibodies, enzymes, and virus-like particles.
Latest Patents
Anne Kalling holds a patent titled "Viral expression plasmids for production of proteins, antibodies, enzymes, virus-like particles and for use in cell-based assays." This patent reveals that the EBV FR-element, which consists of EBNA1 multimeric binding sites, can provide stable maintenance replication functions to mouse polyomavirus (PyV) core origin plasmids in the presence of BPV-1 E2 protein and PyV large T-antigen (LT). She has 1 patent to her name.
Career Highlights
Kalling is associated with Icosagen Cell Factory OÜ, where she continues to advance her research and innovations. Her work at Icosagen focuses on harnessing the potential of viral expression systems for various applications in biotechnology.
Collaborations
Anne collaborates with esteemed colleagues, including Tiiu Mandel and Ingrid Tagen, who contribute to her research endeavors and help drive innovation in the field.
Conclusion
Anne Kalling's contributions to biotechnology through her innovative patents and collaborations highlight her role as a leading inventor in her field. Her work continues to influence advancements in protein production and cell-based assays.